Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 30 min ago
Peer-reviewedCC BY 4.0PLOS One

Streamlining recombinant peptide and protein production using a pre-configured elastin-like polypeptide expression cassette

  1. 1Bridge Institute, Michelson Center for Convergent Bioscience, Structure Biology Center, University of Southern California, Los Angeles, California, United States of America
  2. 2Bridge Institute, Michelson Center for Convergent Bioscience, University of Southern California, Los Angeles, California, United States of America

Abstract

Elastin-like polypeptides (ELPs) are synthetic biopolymers that exhibit a unique thermo-responsive behavior: they remain soluble below a defined transition temperature but undergo reversible aggregation when the temperature exceeds this threshold. This property enables a simplified, non-chromatographic protein purification strategy. Despite these advantages, ELP-based purification has not yet been widely adopted as a standard method in research laboratories, indicating that certain practical limitations or challenges remain to be addressed. The first major challenge is the absence of a standardized ELP-tagged protein expression cassette suitable for use in research laboratories. The second is the development of an effective strategy for purifying the target protein released from the ELP tag following enzymatic cleavage. In this study, we present an optimized and modular gene cassette designed to standardize ELP-tagged peptide that can operates under mild conditions, featuring a low inverse transition temperature (Tt) of 27–31 °C, reduced salt concentrations (up to 0.5 M NaCl), and produces high yield and high purity product. Additionally, we exploited the ELP’s concentration induced aggregation to facilitate its separation from the target protein by filtration following enzymatic cleavage to address the second challenge. Here, we emphasize that this protocol has proven to be particularly efficient for the purification of small peptides, primarily due to the substantial size difference between the target peptide and the ELP tag. The purification of larger peptides remains feasible but may require alternative purification strategies. As a case study, we illustrate the purification of human β-defensin 1 (hBD-1; gene DEFB1), a 36-residue antimicrobial peptide, and discuss the challenges encountered and solutions implemented during the purification process.

Related

  1. Recombinant SIRT1 expression and SIRT1 METTL3 interaction analysis with computational identification of phytochemical SIRT1 activators and inhibitors
    M. K. E. Hasan, M. N. H. Joy, L. Lin +11
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  2. Expression and Purification of Recombinant Duck Ovalbumin in Escherichia coli
    Miryam Madeleine Therese, Antonius Suwanto, Nisa Rachmania Mubarik
    Hayati Journal of BiosciencesPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationDOAJ
  3. Mammalian recombinant production of mature peptide hormone insulin-like 3 (INSL3)
    Xunan Wang, Rebecca J. Metivier, Eric S. Fischer +1
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  4. RNA thermometers as temperature-dependent tools for enhanced recombinant protein production in precision fermentation.
    Christina Peternell, Philipp Noll, Marius Henkel
    Microbial cell factoriesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. Iron oxide nanoparticle-mediated elicitation enhances secondary metabolite production, antioxidant activity, and gene expression in Melia azedarach L
    Vahid Rabbani, Ghasem-Ali Garoosi, Raheem Haddad +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@article{lobos2026streamlining,
  title = {{Streamlining recombinant peptide and protein production using a pre-configured elastin-like polypeptide expression cassette}},
  author = {Jetson Lobos and Jeffrey Velasquez and Fariborz Nasertorabi},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0357387},
  url = {https://doi.org/10.1371/journal.pone.0357387},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Streamlining recombinant peptide and protein production using a pre-configured elastin-like polypeptide expression cassette
AU  - Jetson Lobos
AU  - Jeffrey Velasquez
AU  - Fariborz Nasertorabi
PY  - 2026
DA  - 2026/09/11
JO  - PLOS One
DO  - 10.1371/journal.pone.0357387
UR  - https://doi.org/10.1371/journal.pone.0357387
AB  - Elastin-like polypeptides (ELPs) are synthetic biopolymers that exhibit a unique thermo-responsive behavior: they remain soluble below a defined transition temperature but undergo reversible aggregation when the temperature exceeds this threshold. This property enables a simplified, non-chromatographic protein purification strategy. Despite these advantages, ELP-based purification has not yet been widely adopted as a standard method in research laboratories, indicating that certain practical limitations or challenges remain to be addressed. The first major challenge is the absence of a standardized ELP-tagged protein expression cassette suitable for use in research laboratories. The second is the development of an effective strategy for purifying the target protein released from the ELP tag following enzymatic cleavage. In this study, we present an optimized and modular gene cassette designed to standardize ELP-tagged peptide that can operates under mild conditions, featuring a low inverse transition temperature (Tt) of 27–31 °C, reduced salt concentrations (up to 0.5 M NaCl), and produces high yield and high purity product. Additionally, we exploited the ELP’s concentration induced aggregation to facilitate its separation from the target protein by filtration following enzymatic cleavage to address the second challenge. Here, we emphasize that this protocol has proven to be particularly efficient for the purification of small peptides, primarily due to the substantial size difference between the target peptide and the ELP tag. The purification of larger peptides remains feasible but may require alternative purification strategies. As a case study, we illustrate the purification of human β-defensin 1 (hBD-1; gene DEFB1), a 36-residue antimicrobial peptide, and discuss the challenges encountered and solutions implemented during the purification process.
SN  - 1932-6203
ER  -